For: | Piratvisuth T, Han GR, Pol S, Dong Y, Trylesinski A. Comprehensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol 2016; 8(9): 452-460 [PMID: 27028961 DOI: 10.4254/wjh.v8.i9.452] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i9/452.htm |
Number | Citing Articles |
1 |
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis. Gastroenterología y Hepatología 2020; 43(10): 640 doi: 10.1016/j.gastrohep.2020.03.015
|
2 |
Mark R. Schleiss, Ketzela J. Marsh. Avery's Diseases of the Newborn. 2018; : 482 doi: 10.1016/B978-0-323-40139-5.00037-1
|
3 |
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
|
4 |
Xiaojun Sun, Chengwei Wang, Bian Wang, Xiuzhen Yang, Hongtao Xu, Meilong Shen, Kuichun Zhu, Susan Cu-Uvin. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group. Infectious Diseases in Obstetrics and Gynecology 2020; 2020: 1 doi: 10.1155/2020/4305950
|
5 |
Er-Mei Li, Li-Xin Xiao, Zhen Xu, Zhi-Shuo Mo, Jia-Qian Li, Yong-Yu Mei, Chao-Shuang Lin. Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy. BMC Pregnancy and Childbirth 2021; 21(1) doi: 10.1186/s12884-021-04020-z
|
6 |
Wei Yi, Xiuzhen Cao, Zhan Zeng, Weihua Cao, Ying Zhang, Fangfang Sun, Ying Wang, Gang Wan, Minghui Li, Yao Xie. Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up. Virulence 2021; 12(1): 1527 doi: 10.1080/21505594.2021.1936769
|
7 |
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
|
8 |
Jinfeng Liu, Jing Wang, Taotao Yan, Dan Du, Caijing Qi, Furong Cao, Naijuan Yao, Yuan Yang, Yingli He, Zhen Tian, Danfeng Ren, Li Zhu, Tianyan Chen, Yingren Zhao. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practice. Journal of Viral Hepatitis 2019; 26(10): 1170 doi: 10.1111/jvh.13156
|
9 |
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment. Journal of Viral Hepatitis 2017; 24(S1): 6 doi: 10.1111/jvh.12787
|
10 |
Dost Sarpel, Tatyana Kushner, Danielle Carter, Tsipora Huisman, Sophia Chiu, Douglas Dieterich. Mother-to-child Transmission of Hepatitis B and C Virus: Review of the Epidemiology and Current Treatment Options. Future Virology 2018; 13(1): 43 doi: 10.2217/fvl-2017-0069
|
11 |
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis. Gastroenterología y Hepatología (English Edition) 2020; 43(10): 640 doi: 10.1016/j.gastre.2020.03.012
|